Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02790983 · ClinicalTrials.gov registry record
Primary Tumor Research and Outcomes Network
A clinical trial of Spinal Column Tumor, sponsored by AO Innovation Translation Center.
- Recruiting
- Registry status
- 1,350
- Enrollment target
- 19
- Study locations
NCT02790983: Recruiting study of Spinal Column Tumor, sponsored by AO Innovation Translation Center.
NCT02790983 is a study of Spinal Column Tumor that is actively recruiting participants, run by AO Innovation Translation Center. The registered enrollment target is 1,350 participants. The trial reports 19 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02790983, a study of Spinal Column Tumor, is actively recruiting participants, sponsored by AO Innovation Translation Center.
- RECRUITING
- Registry status
- 1,350 participants
- Enrollment target
- 19
- Study locations
Study Summary
This project aims to establish a network of spine oncology centers dedicated to prospective multicenter research of patients diagnosed with a primary tumor of the spine and will include a comprehensive prospective clinical database which will serve as a shared research platform. Demographic, clinical, diagnostic, and therapeutic variables will be used to answer questions about survival and local recurrence, as well as questions about adverse events (AEs), morbidity data, and health-related quality of life (HRQOL) outcomes.
Primary Outcome
FU visits will be scheduled and performed according to the local standard of care and at each scheduled visit the patient's survival will be documented. In case a patient misses a scheduled visit it will be assessed if the patient is still alive
Conditions Studied
Study Locations (19)
Other
- University of Queensland, School of Medicine - Brisbane
- Universitaetsklinikum Carl Gustav Carus der Techn. Universitaet - Dresden - Dresden
- National Center for Spinal Disorders and Buda Health Center - Budapest
- Istituto Ortopedico Rizzoli - Bologna
- IRCCS Istituto Ortopedico Galeazzi - Milan
- Kanazawa Medical University Hospital - Kanazawa
- Oxford University Hospitals - Oxford
California
- University of California - Los Angeles
- UCSF Medical Center - San Francisco
New York
- Memorial Sloan-Kettering Cancer Center - New York
- Memorial Sloan Kettering Cancer Center - New York
Maryland
- Johns Hopkins University School of Medicine - Baltimore
Massachusetts
- Massachusetts General Hospital - Boston
Minnesota
- Mayo Clinic - Rochester
Rhode Island
- Rhode Island Hospital - Providence
Texas
- The University of Texas M.D. Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,350 participants |
| Start Date | 2016-10 |
| Est. Completion | 2028-12 |
What NCT02790983 shows while recruiting
NCT02790983 is an observational study that tracks outcomes without assigning an intervention. Its 1,350 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Spinal Column Tumor appearing as the primary indexed condition, and to 0 interventions.
NCT02790983 lists 19 locations in 11 states (Other, California, New York).
Frequently Asked Questions
What is clinical trial NCT02790983 about?
NCT02790983 is a clinical study titled "Primary Tumor Research and Outcomes Network". This project aims to establish a network of spine oncology centers dedicated to prospective multicenter research of patients diagnosed with a primary tumor of the spine and will include a comprehensive prospective clinical database which will serve as a shared research platform. Demographic, clinica...
What is the current status of trial NCT02790983?
This trial is currently recruiting. The enrollment target is 1,350 participants. The study started on 2016-10. Estimated completion is 2028-12.
What conditions does trial NCT02790983 study?
This clinical trial studies the following conditions: Spinal Column Tumor.
Who is sponsoring clinical trial NCT02790983?
This trial is sponsored by AO Innovation Translation Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02790983 being conducted?
This trial has 19 study locations across California, Maryland, Massachusetts, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06318169 · 1,350 participants · Phase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- NCT06605404 · 1,350 participants
Pan-tumor MRD Study
- NCT06806163 · 1,350 participants · NA
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
- NCT06731608 · 1,344 participants · NA
OsteoPorotic fracTure preventION System (OPTIONS) Research Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia